CS-121 APOC3 Base Editing in Severe Hypertriglyceridemia

Clinical trial NCT07657780 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07657780
Sponsor: CorrectSequence Therapeutics Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Severe Hypertriglyceridemia (sHTG)

Start date: 2026-06-15
Primary completion: 2028-03-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.